Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article Full Text Full Text (PDF) PPT slides of all figures Alert me when this article is cited Citation Map Services Email this article Similar articles in this journal Similar articles in PubMed Alert me to new content in the JEM Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Google Scholar Google Scholar Articles by Lurquin, C. Articles by Boon, T. Search for Related Content PubMed PubMed Citation Articles by Lurquin, C. Articles by Boon, T. Related Collections Related Article Social Bookmarking                      What's this?

¹ Cellular Genetics Unit, Université de Louvain, B-1200 Brussels, Belgium
² Department of Pathology, Université de Louvain, B-1200 Brussels, Belgium
³ Ludwig Institute for Cancer Research, Brussels Branch, B-1200 Brussels, Belgium

CORRESPONDENCE Thierry Boon: thierry.boon{at}bru.licr.org

Melanoma patients have high frequencies of T cells directed against antigens of their tumor. The frequency of these antitumor T cells in the blood is usually well above that of the anti-vaccine T cells observed after vaccination with tumor antigens. In a patient vaccinated with a MAGE-3 antigen presented by HLA-A1, we measured the frequencies of anti-vaccine and antitumor T cells in several metastases to evaluate their respective potential contribution to tumor rejection. The frequency of anti–MAGE-3.A1 T cells was 1.5 x 10^–5 of CD8 T cells in an invaded lymph node, sixfold higher than in the blood. An antitumor cytotoxic T lymphocyte (CTL) recognizing a MAGE-C2 antigen showed a much higher enrichment with a frequency of 10%, 1,000 times higher than its blood frequency. Several other antitumor T clonotypes had frequencies >1%. Similar findings were made on a regressing cutaneous metastasis. Thus, antitumor T cells were 10,000 times more frequent than anti-vaccine T cells inside metastases, representing the majority of T cells present there. This suggests that the anti-vaccine CTLs are not the effectors that kill the bulk of the tumor cells, but that their interaction with the tumor generates conditions enabling the stimulation of large numbers of antitumor CTLs that proceed to destroy the tumor cells. Naive T cells appear to be stimulated in the course of this process as new antitumor clonotypes arise after vaccination.

CiteULike

Complore

Connotea

Del.icio.us

Digg

Reddit

Technorati

This article has been cited by other articles:

• El Hage, F., Stroobant, V., Vergnon, I., Baurain, J.-F., Echchakir, H., Lazar, V., Chouaib, S., Coulie, P. G., Mami-Chouaib, F. (2008). Preprocalcitonin signal peptide generates a cytotoxic T lymphocyte-defined tumor epitope processed by a proteasome-independent pathway. Proc. Natl. Acad. Sci. USA 105: 10119-10124 [Abstract] [Full Text]  
• Willimsky, G., Czeh, M., Loddenkemper, C., Gellermann, J., Schmidt, K., Wust, P., Stein, H., Blankenstein, T. (2008). Immunogenicity of premalignant lesions is the primary cause of general cytotoxic T lymphocyte unresponsiveness. J. Exp. Med. 205: 1687-1700 [Abstract] [Full Text]  
• Palmer, D. C., Chan, C.-C., Gattinoni, L., Wrzesinski, C., Paulos, C. M., Hinrichs, C. S., Powell, D. J. Jr., Klebanoff, C. A., Finkelstein, S. E., Fariss, R. N., Yu, Z., Nussenblatt, R. B., Rosenberg, S. A., Restifo, N. P. (2008). From the Cover: Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity. Proc. Natl. Acad. Sci. USA 105: 8061-8066 [Abstract] [Full Text]  
• Connerotte, T., Van Pel, A., Godelaine, D., Tartour, E., Schuler-Thurner, B., Lucas, S., Thielemans, K., Schuler, G., Coulie, P. G. (2008). Functions of Anti-MAGE T-Cells Induced in Melanoma Patients under Different Vaccination Modalities. Cancer Res. 68: 3931-3940 [Abstract] [Full Text]  
• Goldberger, O., Volovitz, I., Machlenkin, A., Vadai, E., Tzehoval, E., Eisenbach, L. (2008). Exuberated Numbers of Tumor-Specific T Cells Result in Tumor Escape. Cancer Res. 68: 3450-3457 [Abstract] [Full Text]  
• Carrasco, J., Van Pel, A., Neyns, B., Lethe, B., Brasseur, F., Renkvist, N., van der Bruggen, P., van Baren, N., Paulus, R., Thielemans, K., Boon, T., Godelaine, D. (2008). Vaccination of a Melanoma Patient with Mature Dendritic Cells Pulsed with MAGE-3 Peptides Triggers the Activity of Nonvaccine Anti-Tumor Cells. J. Immunol. 180: 3585-3593 [Abstract] [Full Text]  
• Slingluff, C. L. Jr., Petroni, G. R., Chianese-Bullock, K. A., Smolkin, M. E., Hibbitts, S., Murphy, C., Johansen, N., Grosh, W. W., Yamshchikov, G. V., Neese, P. Y., Patterson, J. W., Fink, R., Rehm, P. K. (2007). Immunologic and Clinical Outcomes of a Randomized Phase II Trial of Two Multipeptide Vaccines for Melanoma in the Adjuvant Setting. Clin. Cancer Res. 13: 6386-6395 [Abstract] [Full Text]  
• Gajewski, T. F. (2007). Failure at the Effector Phase: Immune Barriers at the Level of the Melanoma Tumor Microenvironment. Clin. Cancer Res. 13: 5256-5261 [Abstract] [Full Text]  
• Inokuma, M., dela Rosa, C., Schmitt, C., Haaland, P., Siebert, J., Petry, D., Tang, M., Suni, M. A., Ghanekar, S. A., Gladding, D., Dunne, J. F., Maino, V. C., Disis, M. L., Maecker, H. T. (2007). Functional T Cell Responses to Tumor Antigens in Breast Cancer Patients Have a Distinct Phenotype and Cytokine Signature. J. Immunol. 179: 2627-2633 [Abstract] [Full Text]  
• Boissonnas, A., Fetler, L., Zeelenberg, I. S., Hugues, S., Amigorena, S. (2007). In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor. J. Exp. Med. 204: 345-356 [Abstract] [Full Text]  
• Parmiani, G., De Filippo, A., Novellino, L., Castelli, C. (2007). Unique Human Tumor Antigens: Immunobiology and Use in Clinical Trials. J. Immunol. 178: 1975-1979 [Abstract] [Full Text]  
• Roman-Gomez, J., Jimenez-Velasco, A., Agirre, X., Castillejo, J. A., Navarro, G., San Jose-Eneriz, E., Garate, L., Cordeu, L., Cervantes, F., Prosper, F., Heiniger, A., Torres, A. (2007). Epigenetic regulation of human cancer/testis antigen gene, HAGE, in chronic myeloid leukemia. haematol 92: 153-162 [Abstract] [Full Text]  
• Lesimple, T., Neidhard, E.-M., Vignard, V., Lefeuvre, C., Adamski, H., Labarriere, N., Carsin, A., Monnier, D., Collet, B., Clapisson, G., Birebent, B., Philip, I., Toujas, L., Chokri, M., Quillien, V. (2006). Immunologic and Clinical Effects of Injecting Mature Peptide-Loaded Dendritic Cells by Intralymphatic and Intranodal Routes in Metastatic Melanoma Patients. Clin. Cancer Res. 12: 7380-7388 [Abstract] [Full Text]  
• Udagawa, M., Kudo-Saito, C., Hasegawa, G., Yano, K., Yamamoto, A., Yaguchi, M., Toda, M., Azuma, I., Iwai, T., Kawakami, Y. (2006). Enhancement of Immunologic Tumor Regression by Intratumoral Administration of Dendritic Cells in Combination with Cryoablative Tumor Pretreatment and Bacillus Calmette-Guerin Cell Wall Skeleton Stimulation. Clin. Cancer Res. 12: 7465-7475 [Abstract] [Full Text]  
• Carrasco, J., Godelaine, D., Van Pel, A., Boon, T., van der Bruggen, P. (2006). CD45RA on human CD8 T cells is sensitive to the time elapsed since the last antigenic stimulation. Blood 108: 2897-2905 [Abstract] [Full Text]  
• Vezys, V., Masopust, D., Kemball, C. C., Barber, D. L., O'Mara, L. A., Larsen, C. P., Pearson, T. C., Ahmed, R., Lukacher, A. E. (2006). Continuous recruitment of naive T cells contributes to heterogeneity of antiviral CD8 T cells during persistent infection. J. Exp. Med. 203: 2263-2269 [Abstract] [Full Text]  
• Ferrone, C. R., Perales, M.-A., Goldberg, S. M., Somberg, C. J., Hirschhorn-Cymerman, D., Gregor, P. D., Turk, M. J., Ramirez-Montagut, T., Gold, J. S., Houghton, A. N., Wolchok, J. D. (2006). Adjuvanticity of plasmid DNA encoding cytokines fused to immunoglobulin fc domains.. Clin. Cancer Res. 12: 5511-5519 [Abstract] [Full Text]  
• Shimizu, K., Hidaka, M., Kadowaki, N., Makita, N., Konishi, N., Fujimoto, K., Uchiyama, T., Kawano, F., Taniguchi, M., Fujii, S.-i. (2006). Evaluation of the Function of Human Invariant NKT Cells from Cancer Patients Using {alpha}-Galactosylceramide-Loaded Murine Dendritic Cells.. J. Immunol. 177: 3484-3492 [Abstract] [Full Text]  
• Sensi, M., Anichini, A. (2006). Unique Tumor Antigens: Evidence for Immune Control of Genome Integrity and Immunogenic Targets for T Cell-Mediated Patient-Specific Immunotherapy. Clin. Cancer Res. 12: 5023-5032 [Abstract] [Full Text]  
• Appay, V., Jandus, C., Voelter, V., Reynard, S., Coupland, S. E., Rimoldi, D., Lienard, D., Guillaume, P., Krieg, A. M., Cerottini, J.-C., Romero, P., Leyvraz, S., Rufer, N., Speiser, D. E. (2006). New Generation Vaccine Induces Effective Melanoma-Specific CD8+ T Cells in the Circulation but Not in the Tumor Site. J. Immunol. 177: 1670-1678 [Abstract] [Full Text]  
• Lesterhuis, W. J., de Vries, I. J. M., Schuurhuis, D. H., Boullart, A. C. I., Jacobs, J. F. M., de Boer, A. J., Scharenborg, N. M., Brouwer, H. M. H., van de Rakt, M. W. M. M., Figdor, C. G., Ruers, T. J., Adema, G. J., Punt, C. J. A. (2006). Vaccination of colorectal cancer patients with CEA-loaded dendritic cells: antigen-specific T cell responses in DTH skin tests. Ann Oncol 17: 974-980 [Abstract] [Full Text]  
• Vuylsteke, R. J.C.L.M., Molenkamp, B. G., van Leeuwen, P. A.M., Meijer, S., Wijnands, P. G.J.T.B., Haanen, J. B.A.G., Scheper, R. J., de Gruijl, T. D. (2006). Tumor-Specific CD8+ T Cell Reactivity in the Sentinel Lymph Node of GM-CSF-Treated Stage I Melanoma Patients is Associated with High Myeloid Dendritic Cell Content.. Clin. Cancer Res. 12: 2826-2833 [Abstract] [Full Text]  
• van Baren, N., Bonnet, M.-C., Dreno, B., Khammari, A., Dorval, T., Piperno-Neumann, S., Lienard, D., Speiser, D., Marchand, M., Brichard, V. G., Escudier, B., Negrier, S., Dietrich, P.-Y., Maraninchi, D., Osanto, S., Meyer, R. G., Ritter, G., Moingeon, P., Tartaglia, J., van der Bruggen, P., Coulie, P. G., Boon, T. (2005). Tumoral and Immunologic Response After Vaccination of Melanoma Patients With an ALVAC Virus Encoding MAGE Antigens Recognized by T Cells. JCO 23: 9008-9021 [Abstract] [Full Text]  
• Gure, A. O., Chua, R., Williamson, B., Gonen, M., Ferrera, C. A., Gnjatic, S., Ritter, G., Simpson, A. J.G., Chen, Y.-T., Old, L. J., Altorki, N. K. (2005). Cancer-Testis Genes Are Coordinately Expressed and Are Markers of Poor Outcome in Non-Small Cell Lung Cancer. Clin. Cancer Res. 11: 8055-8062 [Abstract] [Full Text]  
• Vignard, V., Lemercier, B., Lim, A., Pandolfino, M.-C., Guilloux, Y., Khammari, A., Rabu, C., Echasserieau, K., Lang, F., Gougeon, M.-L., Dreno, B., Jotereau, F., Labarriere, N. (2005). Adoptive Transfer of Tumor-Reactive Melan-A-Specific CTL Clones in Melanoma Patients Is Followed by Increased Frequencies of Additional Melan-A-Specific T Cells. J. Immunol. 175: 4797-4805 [Abstract] [Full Text]  

Home | Help | Feedback | Subscriptions | Archive | Search

TABLE OF CONTENTS